Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia.

ABSTRACT:

SUBMITTER: Martinelli S 

PROVIDER: S-EPMC6269319 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature